FDA Inspection 698666 — K.W. Griffen Company

K.W. Griffen Company — FEI 1211177

The FDA completed an inspection of K.W. Griffen Company on Nov 18, 2010 in Norwalk, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 18, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Norwalk, CT (United States)

Citations

IDCFRDescription
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
435521 CFR 211.165(c)Sampling and testing plans not followed
440221 CFR 211.192Written record of investigation incomplete

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.